Absolute CVD risk estimates in the largest possible sample (n=3012) and stratified by sex and age group (<60 and ≥60 years of age) for different categories of LDL levels, stratified by use of lipid-lowering medication
| Overall sample | Women | Men | ||||||
| LDL group | LDL treatment | Events (n)/At risk (n) | Crude CVD event rates (95% CI)* | Events (n)/At risk (n) | Crude CVD event rates (95% CI)* | Events (n)/At risk (n) | Crude CVD event rates (95% CI)* | |
| 1 | <100 mg/dL | No | 62/546 | 9.0 (6.8 to 11.3) | 36/348 | 8.0 (5.4 to 10.6) | 26/198 | 10.9 (6.7 to 15.1) |
| 2 | ≥100 to <130 mg/dL | No | 164/931 | 14.0 (11.9 to 16.2) | 74/506 | 11.4 (8.8 to 14.1) | 90/425 | 17.2 (13.7 to 20.8) |
| 3 | <130 mg/dL | Yes | 52/170 | 26.7 (19.5 to 34.0) | 24/75 | 26.8 (16.1 to 37.5) | 28/95 | 26.7 (16.8 to 36.5) |
| 4 | ≥130 mg/dL | No | 234/1233 | 15.3 (13.3 to 17.2) | 103/667 | 11.9 (9.6 to 14.3) | 131/566 | 19.5 (16.2 to 22.9) |
| 5 | ≥130 mg/dL | Yes | 36/132 | 24.1 (16.2 to 31.9) | 18/75 | 20.4 (10.9 to 29.8) | 18/57 | 29.5 (15.9 to 43.1) |